| http://www.w3.org/ns/prov#value | - treatment with the said drug.BRIEF DESCRIPTION OF THE DRAWINGSFIG. 1 is a flow chart showing a method for selection of CRC patients for treatment with EGFR-I in accordance with a preferred embodiment of this invention.FIG. 2 is a Kaplan-Meier plot for a set of colorectal cancer patients treated with cetuximab and the class label assigned to serum samples using the method of FIG. 1.
|
